Concepedia

Fandong Meng

FM

15

Publications

907

Citations

15

H-Index

2014

Active since

Affiliations

China Medical University(Current)

First Hospital of China Medical University

Liaoning Cancer Hospital & Institute

Fandong Meng is an author at China Medical University specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

2014–2021

15

Publications

15

Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK/elF2α/ATF4/CHOP pathway in breast cancer

Xiaoxi Li, Jian Zheng, Shi Chen et al. · Cell Death and Disease · 2021 · 151 citations · Full text

Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation

Rongqing Li, Xueqin Li, Jie Zhao et al. · Theranostics · 2021 · 146 citations · Full text

The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway

Yuanqin Yin, Chengguang Sui, Fandong Meng et al. · Lipids in Health and Disease · 2017 · 88 citations · Full text

MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55

Yuanqin Yin, Jingjing Cai, Fandong Meng et al. · Cancer Biology & Therapy · 2018 · 69 citations · Full text

Bufalin loaded biotinylated chitosan nanoparticles: An efficient drug delivery system for targeted chemotherapy against breast carcinoma

Xin Tian, Hongzhuan Yin, Shichen Zhang et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2014 · 64 citations

, , +10

Rows per page

1–5 of 15